Financial News
Articles published by The Motley Fool

I Got Wonderful Gifts for a Family of 5 for Only $85. Here's How
December 01, 2023
Via The Motley Fool

Could Bitcoin Be Worth More Than $1 Trillion in 2024?
December 01, 2023
Via The Motley Fool


Is This the Savings Milestone You Should Reach Before Retirement?
December 01, 2023
Via The Motley Fool
Topics
Retirement
Exposures
Pension

Better Buy: Rivian vs. Nio Stock
December 01, 2023
Via The Motley Fool
Topics
Electric Vehicles
Exposures
Electric Vehicles

Mark Zuckerberg's $50 Billion Blunder
December 01, 2023
Via The Motley Fool

The 6 Best Men's Gifts to Buy at Target
December 01, 2023
Via The Motley Fool


Why CrowdStrike Holdings Stock Jumped 12% This Week
December 01, 2023
Via The Motley Fool
Tickers
CRWD

1 Semiconductor Stock You'll Regret Not Buying Right Now
December 01, 2023
Via The Motley Fool
Tickers
TSM

Via The Motley Fool
Tickers
O

This Restaurant Stock Dwarfs Chipotle in These Key Metrics
December 01, 2023
Via The Motley Fool




3 HSA Rules You Really Need to Know
December 01, 2023
Via The Motley Fool

1 Green Flag for Advanced Micro Devices Stock in 2023, and 1 Red Flag
December 01, 2023
Via The Motley Fool
Tickers
AMD


2 Top Buffett Stocks to Buy and Hold for the Long Haul
December 01, 2023
Via The Motley Fool

3 AI Stocks to Kick Off 2024
December 01, 2023
Via The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence

Down 90%, Is Rivian Stock a Can't-Miss Buy at These Prices?
December 01, 2023
Via The Motley Fool

Despite a Record Quarter, I'm Still Not Sold on Tapestry Stock
December 01, 2023
Via The Motley Fool


Carnival Cruise Lines Stock: Buy, Sell, or Hold?
December 01, 2023
Via The Motley Fool


Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
December 01, 2023
Via The Motley Fool


Cathie Wood Is Loading Up on This 1 Innovative Growth Stock Down 86%
December 01, 2023
Via The Motley Fool
Tickers
ZM

Why Aurora Cannabis Could Be Active in M&A Again
December 01, 2023
Via The Motley Fool
Topics
Cannabis
Exposures
Cannabis

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
December 01, 2023
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.